SCHEMBL26036030

CC1CC(=O)N(CCC(=O)NCC(C)(C)COCC(C)(C)CC(=O)NCCOc2cc(C(=O)NCC(C)(C)OCC(C)(C)CNC(=O)C(C)(C)CCC(C)(C)C)cc(C(=O)NCC(C)(C)OCC(C)(C)CNC(=O)C(C)(C)CCC(C)(C)C)c2)C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL25840365	0.83	—	—
SCHEMBL26036050	0.81	CNR1 (0.33)	—
SCHEMBL26047285	0.77	CNR1 (0.40)	—
SCHEMBL26047458	0.77	CNR1 (0.40)	—
SCHEMBL25840544	0.77	—	—
SCHEMBL26035877	0.75	OPRK1 (0.33)	—
SCHEMBL26035729	0.74	—	—
SCHEMBL25855492	0.73	NPC1 (0.32)	—
SCHEMBL26037667	0.73	—	—
SCHEMBL25849004	0.71	NPC1 (0.33)	—

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20230265429-A1	SKELETAL MUSCLE DELIVERY PLATFORMS AND METHODS OF USE THEREOF	Arrowhead Pharmaceuticals, Inc.	2023-08-24	—	—	US	disclosed